MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BioTime Company Profile (NYSEMKT:BTX)

Consensus Ratings for BioTime (NYSEMKT:BTX) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.50

Analysts' Ratings History for BioTime (NYSEMKT:BTX)
Show:
DateFirmActionRatingPrice TargetActions
4/7/2016Chardan CapitalInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2016OppenheimerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for BioTime (NYSEMKT:BTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/10/2016Q116($0.14)($0.19)$1.43 million$2.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q4($0.17)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115($0.13)$1.10 million$1.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.12)$1.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2014Q214($0.16)$362.25 million$300.08 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q114($0.14)$0.61 million$1.07 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q3($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/18/2013Q412($0.12)$1.70 million$1.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for BioTime (NYSEMKT:BTX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for BioTime (NYSEMKT:BTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for BioTime (NYSEMKT:BTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/21/2016Broadwood Partners LpDirectorBuy2,732,636$2.39$6,531,000.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/20/2016Broadwood Partners LpDirectorBuy300,000$2.35$705,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Alfred D KingsleyInsiderSell100,000$3.83$383,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Stephen C FarrellDirectorBuy50,000$3.83$191,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2015Deborah J AndrewsDirectorBuy2,000$2.82$5,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Stephen Lahue CarttDirectorBuy75,000$2.80$210,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2014David SchlachetDirectorBuy32,050$3.12$99,996.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Broadwood Partners LpDirectorBuy370,000$2.65$980,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Michael D WestCEOSell270,000$2.65$715,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Robert PeabodyCFOSell100,000$2.65$265,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2014William P Phd TewInsiderSell30,000$3.07$92,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Broadwood Partners LpDirectorBuy1,000,000$2.50$2,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2014Broadwood Partners LpDirectorBuy300,000$2.45$735,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014Broadwood Partners LpDirectorBuy300,000$2.44$732,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Broadwood Partners LpDirectorBuy2,000,000$2.52$5,040,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2014Broadwood Partners LpDirectorBuy500,000$3.74$1,870,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2013Neal C BradsherDirectorBuy300,042$3.51$1,053,147.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2013William P Phd TewInsiderSell13,860$3.76$52,113.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013Stephen C FarrellDirectorBuy11,213$3.89$43,618.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2013Stephen C FarrellDirectorBuy4,187$3.65$15,282.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2013Eschenbach Andrew C VonDirectorBuy3,000$3.69$11,070.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2013Broadwood Partners LpDirectorBuy200,000$3.81$762,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2012Broadwood Partners LpDirectorBuy344,828$2.90$1,000,001.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for BioTime (NYSEMKT:BTX)
DateHeadline
06/26/16 08:10 AMAnalysts Review: BioTime, Inc. (NYSEMKT:BTX) - iStreetWire
06/22/16 03:08 PMBioTime, Inc. Announces Closing of Public Offering of Common Stock - Business Wire (press release)
06/21/16 11:19 AMBioTime, Inc. Announces Closing of Public Offering of Common Stock - [at noodls] - BioTime, Inc. Announces Closing of Public Offering of Common Stock The text version of this document is not available at the moment. The original content was posted at original link . BioTime Inc. published ...
06/20/16 09:24 AMHealthcare Unusual Volume: ViewRay, Inc. (NASDAQ:VRAY), BioTime, Inc. (NYSEMKT:BTX), Innocoll Holdings plc ... - KC Register
06/18/16 07:39 AMBioTime Inc. (BTX) Drops 7.69% on June 16 - Equities.com
06/17/16 02:51 PMBioTime, Inc. (NYSEMKT:BTX) Eyes $17.5 Million IPO - Scibility Media
06/17/16 01:13 PMBIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits -
06/16/16 08:19 PMBioTime (BTX) Prices 7.3M Stock Offering at $2.39/Share
06/16/16 02:57 PMBiggest Movers in Manufacturing Stocks Now – QLGC VBIV BLPH AMD - Investorplace.com
06/16/16 02:57 PMBioTime (BTX) Prices 7.3M Stock Offering at $2.39/Share - StreetInsider.com
06/16/16 11:08 AMA Look at Five Stocks that Are Trending on Thursday -
06/16/16 09:39 AMBioTime, Inc. Announces Pricing of Public Offering of Common Stock - [at noodls] - ALAMEDA, Calif.--(BUSINESS WIRE)--Jun. 16, 2016-- BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative ...
06/16/16 07:21 AMAfter-Hours Stock Movers 06/15: (QLGC) (RLYP) (NUS) Higher; (EVHC) (BTX) (KFY) Lower (more...) - StreetInsider.com
06/16/16 07:21 AMBioTime, Inc. Announces Proposed Public Offering of Common Stock - Business Wire (press release)
06/15/16 04:19 PMBIOTIME INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/15/16 03:19 PMBioTime, Inc. Announces Proposed Public Offering of Common Stock - [at noodls] - ALAMEDA, Calif.--(BUSINESS WIRE)--Jun. 15, 2016-- BioTime, Inc. (NYSE MKT:BTX), a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative ...
06/13/16 03:16 PMToday's Hot List: Corium International, (NASDAQ:CORI), BioTime, (NYSEMKT:BTX), Discovery Communications ... - KC Register
06/13/16 03:16 PMBioTime (BTX), Cell Cure Receive DSMB Approval to Move Forward with OpRegen Phase 1/2a Enrollment - StreetInsider.com
06/13/16 10:58 AMBiotime to up dosage for OpRegen in phase I/II trial
06/13/16 06:19 AMBioTime’s Subsidiary Cell Cure Neurosciences Receives DSMB Approval to Start Second Patient Cohort in Clinical Trial for Dry-AMD - [at noodls] - BioTime's Subsidiary Cell Cure Neurosciences Receives DSMB Approval to Start Second Patient Cohort in Clinical Trial for Dry-AMD - Safety Confirmed with No Concerns Reported in Cohort 1 - - Approval to ...
06/10/16 11:29 AMBioTime (BTX) Unit Receives $2.2M Grant for Development of OpRegen in Dry-AMD - StreetInsider.com
06/10/16 11:29 AMBioTime Inc. (BTX) is Trading Higher on Unusual Volume for June 08 - Equities.com
06/10/16 08:49 AMBioTime Announces $2.2 Million Grant for Further Development of Dry-AMD Program - [at noodls] - - Israel Innovation Authority awards a grant to Cell Cure Neurosciences, a BioTime Subsidiary, that will support ongoing development of OpRegen®, to address a leading cause of blindness, dry-AMD - This ...
06/09/16 11:34 AMBioTime to Present at the Jefferies 2016 Global Healthcare Conference - Digital Journal
06/09/16 06:19 AMBioTime to Present at the Jefferies 2016 Global Healthcare Conference - [at noodls] - ALAMEDA, Calif.--(BUSINESS WIRE)--Jun. 9, 2016-- BioTime, Inc. (NYSE MKT: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that the ...
06/07/16 04:30 PMETF’s with exposure to BioTime, Inc. : June 7, 2016 -
06/06/16 05:48 AMOncoCyte Presents Positive Bladder Cancer Diagnostic Data at the 2016 American Society of Clinical Oncology Annual Meeting - [at noodls] - ALAMEDA, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE MKT:OCX), a developer of novel, non-invasive tests for the early detection of cancer, is presenting data today from a bladder ...
05/26/16 04:01 PMBIOTIME INC Files SEC form 8-K, Regulation FD Disclosure -
05/26/16 10:15 AMBioTime, Inc. :BTX-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 -
05/21/16 01:54 PMBioTime to Present at Two Upcoming Investor Conferences - Business Wire (press release) - BioTime to Present at Two Upcoming Investor ConferencesBusiness Wire (press release)ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT and TASE: BTX) announced that Co-Chief Executive Officer Michael D. West, Ph.D., will present at the 2016 Oppenheimer 17th Annual Israel Conference to be held at the David Intercontinental ...and more »
05/21/16 01:54 PMBioTime Inc (BTX) Jumps 9.56% on May 20 - Equities.com - BioTime Inc (BTX) Jumps 9.56% on May 20Equities.comBioTime Inc (BTX) was among the biggest gainers on the Russell 2000 for Friday May 20 as the stock popped 9.56% to $2.75, representing a gain of $0.24 per share. Some 187,215 shares traded hands on 753 trades, compared with an average daily volume ...and more »
05/19/16 12:04 PMBIOTIME INC Financials -
05/13/16 08:43 AMBioTime Inc (BTX) Drops 6.94% on May 11 - Equities.com - BioTime Inc (BTX) Drops 6.94% on May 11Equities.comBioTime Inc (BTX) was one of the Russell 2000's biggest losers for Wednesday May 11 as the stock slid 6.94% to $2.68, a loss of $-0.2 per share. Starting at an opening price of $2.84 a share, the stock traded between $2.67 and $2.86 over the course of ...and more »
05/12/16 08:57 AMBioTime, Inc. Reports First Quarter Results and Recent Corporate Accomplishments - Business Wire (press release) - BioTime, Inc. Reports First Quarter Results and Recent Corporate AccomplishmentsBusiness Wire (press release)BUSINESS WIRE)--BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today reported financial results for the first quarter ended March 31, 2016 and provided a ...and more »
05/12/16 08:57 AMBioTime, Inc. (BTX) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS - Washington News Wire - BioTime, Inc. (BTX) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPSWashington News WireBioTime logo BioTime, Inc. (NYSEMKT:BTX) posted its quarterly earnings data on Tuesday. The biotechnology company reported ($0.19) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.14) by $0.05, ARN reports.BioTime, Inc. (BTX) Releases Earnings Results, Misses Estimates By $0.05 EPSNewsWay 21all 2 news articles »
05/07/16 07:56 AMIs Selling Stock Like BioTime, Inc. After Such Decline Winning Strategy? - B.O.D.Y Confidential - Is Selling Stock Like BioTime, Inc. After Such Decline Winning Strategy?B.O.D.Y ConfidentialThe stock of BioTime, Inc. (NYSEMKT:BTX) is a huge mover today! The stock decreased 4.96% or $0.14 on May 6, hitting $2.68. About 209,777 shares traded hands or 28.85% up from the average. BioTime, Inc. (NYSEMKT:BTX) has declined 15.99% since ...and more »
05/06/16 08:30 AMReCyte Therapeutics, a BioTime Subsidiary, Announces Peer-Reviewed Publication on Pericyte-Like Progenitor Cells - Business Wire (press release) - ReCyte Therapeutics, a BioTime Subsidiary, Announces Peer-Reviewed Publication on Pericyte-Like Progenitor CellsBusiness Wire (press release)BUSINESS WIRE)--ReCyte Therapeutics, a subsidiary of BioTime, Inc., a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced the publication of a scientific paper titled, “A novel lineage ...
05/05/16 08:26 AMBiotime Incorporated (NYSEMKT:BTX) Sellers Covered 1.7% of Their Shorts - B.O.D.Y Confidential - Biotime Incorporated (NYSEMKT:BTX) Sellers Covered 1.7% of Their ShortsB.O.D.Y ConfidentialThe short interest to Biotime Incorporated's float is 16.71%. The stock decreased 3.36% or $0.1 during the last trading session, hitting $2.88. About 99,142 shares traded hands. BioTime, Inc. (NYSEMKT:BTX) has declined 1.03% since September 29, 2015 ...
05/04/16 06:59 AMBioTime Inc (BTX) Jumps 6.16% on May 02 - Equities.com - BioTime Inc (BTX) Jumps 6.16% on May 02Equities.comBioTime Inc (BTX) was among the biggest gainers on the Russell 2000 for Monday May 02 as the stock popped 6.16% to $3.10, representing a gain of $0.18 per share. Some 167,939 shares traded hands on 658 trades, compared with an average daily ...and more »
05/02/16 08:55 AMWatch List: athenahealth, Inc. (NASDAQ:ATHN), BioTime, Inc. (NYSEMKT:BTX), Knowles Corporation (NYSE:KN), The ... - KC Register - Watch List: athenahealth, Inc. (NASDAQ:ATHN), BioTime, Inc. (NYSEMKT:BTX), Knowles Corporation (NYSE:KN), The ...KC Registerathenahealth, Inc. (NASDAQ:ATHN) reported that, its bottom line climbed to $13.41 million, or $0.34 per share. This was up from $9.14 million, or $0.24 per share, in last year's first quarter. athenahealth, Inc. (NASDAQ:ATHN) belongs to Technology sector.
04/05/16 02:01 PMBioTime Inc (BTX) Jumps 7.88% on April 04 - Equities.com - BioTime Inc (BTX) Jumps 7.88% on April 04Equities.comBioTime Inc (BTX) was among the biggest gainers on the Russell 2000 for Monday April 04 as the stock popped 7.88% to $3.15, representing a gain of $0.23 per share. Some 378,190 shares traded hands on 1,179 trades, compared with an average daily ...Research Analysts Issue Forecasts for BioTime, Inc.'s Q1 2016 Earnings (BTX)The Vista VoiceRevenue Update on BioTime(NYSEMKT:BTX)Street Editionall 5 news articles »
04/05/16 07:40 AMBioTime Co-CEO Dr. Michael West to Present at Stem Cells in Drug Discovery 2016 in Cambridge, UK - [at noodls] - Will Present on Novel Strategies for the Production of Diverse Pluripotent Stem Cell Types for Drug Discovery ALAMEDA, Calif.--(BUSINESS WIRE)--Apr. 5, 2016-- BioTime, Inc. (NYSE MKT: BTX) today announced ...
04/02/16 12:38 PMBiotime Incorporated (NYSEMKT:BTX) Short Interest Increased By 1.29% - Clinton Financial - Biotime Incorporated (NYSEMKT:BTX) Short Interest Increased By 1.29%Clinton FinancialThe short interest to Biotime Incorporated's float is 17.15%. The stock increased 1.74% or $0.05 on April 1, hitting $2.92. About 251,432 shares traded hands or 29.17% up from the average. BioTime, Inc. (NYSEMKT:BTX) has declined 3.69% since August 25, ...
04/02/16 12:38 PMBioTime, Inc. (NASDAQ:BTX) To Release Earnings - Risers & Fallers - BioTime, Inc. (NASDAQ:BTX) To Release EarningsRisers & FallersAnalysts await BioTime, Inc. (NASDAQ:BTX) to report earnings on Mar, 31 for the fiscal quarter ending Dec 2015. At the moment 2 analysts are watching BioTime, Inc. (NASDAQ:BTX), 1 rate it “Buy”, 1 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”.BIOTIME INC (NYSE:BTX): 2 Analysts Continue to rate NYSE:BTXHints News NetworkBroadwood Capital Inc buys $55.1 Million stake in BioTime (BTX)The Sussex PilotWill BioTime, Inc. Go Down Anytime Soon?SmallCapWired.comall 5 news articles »
04/02/16 12:38 PMHost a Conference Call: BioTime, Inc. (BTX) - share market updates (press release) - Host a Conference Call: BioTime, Inc. (BTX)share market updates (press release)Shares of BioTime, Inc. (NYSEMKT:BTX) ended Wednesday session in green amid volatile trading. The shares closed up +0.10 points or 3.75% at $2.77 with 239,878.00 shares getting traded. Post opening the session at $2.70, the shares hit an intraday low ...
04/02/16 12:38 PMFinancial Results: BioTime, Inc. (BTX) - share market updates (press release) - Financial Results: BioTime, Inc. (BTX)share market updates (press release)Shares of BioTime, Inc. (NYSEMKT:BTX) ended Thursday session in green amid volatile trading. The shares closed up +0.10 points or 3.61% at $2.87 with 4250 shares getting traded. Post opening the session at $2.83, the shares hit an intraday low of $2.76 ...
03/30/16 01:48 PMNew Consensus Analyst Ratings Released for BIOTIME INC (NYSE:BTX) - Hints News Network - New Consensus Analyst Ratings Released for BIOTIME INC (NYSE:BTX)Hints News NetworkAnalysts have issued a 'Strong Buy' rating for BIOTIME INC (NYSE:BTX), according to data recently reviewed by Zacks. The company was rated a “Strong Buy” on average from the 2 analysts who currently cover the stock. 0 of the equities analyst currently ...
03/30/16 01:48 PMHC Recent Stock News: BioTime (BTX), Carbylan Therapeutics (CBYL), Cymabay Therapeutics (CBAY) - share market updates (press release) - share market updates (press release)HC Recent Stock News: BioTime (BTX), Carbylan Therapeutics (CBYL), Cymabay Therapeutics (CBAY)share market updates (press release)Shares of BioTime, Inc. (NYSE:BTX) ended Thursday session in red amid volatile trading. The shares closed down -0.01 points or -0.40% at $2.51.As BioTime, Inc. to Host Conference Call to Update Investors on Recent Accomplishments and Corporate ...and more »
03/30/16 01:48 PMAnalyst's Earnings Roundup: BioTime, Inc. (NYSEMKT:BTX) - The Point Review - The Point ReviewAnalyst's Earnings Roundup: BioTime, Inc. (NYSEMKT:BTX)The Point ReviewWall Street analysts are predicting that BioTime, Inc. (NYSEMKT:BTX) will report earnings per share of $-0.16 in their quarterly report. The firm is expected to announce results on March 31, 2016. BioTime, Inc., a biotechnology company, focuses on ...
03/30/16 01:48 PMBioTime Inc (BTX) Jumps 5.53% on March 29 - Equities.com - BioTime Inc (BTX) Jumps 5.53% on March 29Equities.comBioTime Inc (BTX) was among the biggest gainers on the Russell 2000 for Tuesday March 29 as the stock popped 5.53% to $2.67, representing a gain of $0.14 per share. Some 150,130 shares traded hands on 685 trades, compared with an average daily ...and more »
About BioTime

BioTime logoBioTime, Inc. is a biotechnology company. The Company is focused on the field of regenerative medicine; human embryonic stem (hES) cell and induced pluripotent stem (iPS) cell technology. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. hES and iPS cells provide a means of manufacturing every cell type in the human body. The field of regenerative medicine includes a range of disciplines, including tissue banking, cellular therapy, gene therapy and tissue engineering. The Company is engaged to develop cell-based therapeutic products for diseases, such as neurological disorders, cancer, age related macular degeneration, orthopedic disorders, and age-related cardiovascular disease.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NYSEMKT
  • Symbol: BTX
  • CUSIP: 09066L10
Key Metrics:
  • Previous Close: $2.29
  • 50 Day Moving Average: $2.66
  • 200 Day Moving Average: $2.82
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $216.11M
  • Current Quarter EPS Consensus Estimate: $-0.69 EPS
Additional Links:

            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha